Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with mutations.

Studies of the monogenic autoimmune disease immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) have elucidated the essential function of the transcription factor FOXP3 and thymic-derived regulatory T cells (T) in controlling peripheral tolerance. However, the presence and the source of autoreactive T cells in IPEX remain undetermined. Here, we investigated how FOXP3 deficiency affects the T cell receptor (TCR) repertoire and T stability in vivo and compared T cell abnormalities in patients with IPEX with those in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED). To study T independently of their phenotype and to analyze T cell autoreactivity, we combined T-specific demethylation region analyses, single-cell multiomic profiling, and bulk TCR sequencing. We found that patients with IPEX, unlike patients with APECED, have expanded autoreactive T cells originating from both autoreactive effector T cells (T) and T. In addition, a fraction of the expanded T from patients with IPEX lost their phenotypic and functional markers, including CD25 and FOXP3. Functional experiments with CRISPR-Cas9-mediated FOXP3 knockout T and T from patients with IPEX indicated that the patients' T gain a T2-skewed T-like function, which is consistent with immune dysregulation observed in these patients. Analyses of mutation-carrier mothers and a patient with IPEX after hematopoietic stem cell transplantation indicated that T expressing nonmutated prevent the accumulation of autoreactive T and unstable T. These findings could be directly used for diagnostic and prognostic purposes and for monitoring the effects of immunomodulatory treatments.